These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30727856)

  • 1. DEFUSE 3 Non-DAWN Patients.
    Leslie-Mazwi TM; Hamilton S; Mlynash M; Patel AB; Schwamm LH; Lansberg MG; Marks M; Hirsch JA; Albers GW
    Stroke; 2019 Mar; 50(3):618-625. PubMed ID: 30727856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut-offs might omit potential responders.
    Ducroux C; Khoury N; Lecler A; Blanc R; Chetrit A; Redjem H; Ciccio G; Smajda S; Escalard S; Desilles JP; Mazighi M; Ben Maacha M; Piotin M; Fahed R
    Eur J Neurol; 2018 Aug; 25(8):1093-1099. PubMed ID: 29667266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eligibility for Endovascular Trial Enrollment in the 6- to 24-Hour Time Window: Analysis of a Single Comprehensive Stroke Center.
    Jadhav AP; Desai SM; Kenmuir CL; Rocha M; Starr MT; Molyneaux BJ; Gross BA; Jankowitz BT; Jovin TG
    Stroke; 2018 Apr; 49(4):1015-1017. PubMed ID: 29581344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study.
    Heit JJ; Mlynash M; Kemp SM; Lansberg MG; Christensen S; Marks MP; Ortega-Gutierrez S; Albers GW
    Stroke; 2019 May; 50(5):1172-1177. PubMed ID: 30932783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study.
    Dittrich TD; Sporns PB; Kriemler LF; Rudin S; Nguyen A; Zietz A; Polymeris AA; Tränka C; Thilemann S; Wagner B; Altersberger VL; Piot I; Barinka F; Müller S; Hänsel M; Gensicke H; Engelter ST; Lyrer PA; Sutter R; Nickel CH; Katan M; Peters N; Kulcsár Z; Karwacki GM; Pileggi M; Cereda C; Wegener S; Bonati LH; Fischer U; Psychogios M; De Marchis GM
    Stroke; 2023 Mar; 54(3):722-730. PubMed ID: 36718751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Triage of Patients with Late-Window (6-24 Hours) Acute Ischemic Stroke: A Comparative Study Using Multiphase CT Angiography versus CT Perfusion.
    Almekhlafi MA; Kunz WG; McTaggart RA; Jayaraman MV; Najm M; Ahn SH; Fainardi E; Rubiera M; Khaw AV; Zini A; Hill MD; Demchuk AM; Goyal M; Menon BK
    AJNR Am J Neuroradiol; 2020 Jan; 41(1):129-133. PubMed ID: 31806593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods.
    Jovin TG; Saver JL; Ribo M; Pereira V; Furlan A; Bonafe A; Baxter B; Gupta R; Lopes D; Jansen O; Smith W; Gress D; Hetts S; Lewis RJ; Shields R; Berry SM; Graves TL; Malisch T; Rai A; Sheth KN; Liebeskind DS; Nogueira RG
    Int J Stroke; 2017 Aug; 12(6):641-652. PubMed ID: 28569123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombectomy 6-24 hours after stroke in trial ineligible patients.
    Desai SM; Rocha M; Molyneaux BJ; Starr M; Kenmuir CL; Gross BA; Jankowitz BT; Jovin TG; Jadhav AP
    J Neurointerv Surg; 2018 Nov; 10(11):1033-1037. PubMed ID: 29773716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Periprocedural and Technical Factors and Patient Characteristics on Revascularization and Outcome in the DAWN Trial.
    Tekle WG; Hassan AE; Jadhav AP; Haussen DC; Budzik RF; Bonafe A; Bhuva P; Yavagal DR; Hanel RA; Ribo M; Cognard C; Sila CA; Smith WS; Saver JL; Liebeskind DS; Shields R; Nogueira RG; Jovin TG;
    Stroke; 2020 Jan; 51(1):247-253. PubMed ID: 31744425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center.
    Nannoni S; Strambo D; Sirimarco G; Amiguet M; Vanacker P; Eskandari A; Saliou G; Wintermark M; Dunet V; Michel P
    J Neurointerv Surg; 2020 Sep; 12(9):842-847. PubMed ID: 31772044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombectomy in DAWN- and DEFUSE-3-Ineligible Patients: A Subgroup Analysis From the BEST Prospective Cohort Study.
    Siegler JE; Messé SR; Sucharew H; Kasner SE; Mehta T; Arora N; Starosciak AK; De Los Rios La Rosa F; Barnhill NR; Mistry AM; Patel K; Assad S; Tarboosh A; Dakay K; Salwi S; Wagner J; Bennett A; Jagadeesan BD; Streib C; Weber SA; Chitale R; Volpi JJ; Mayer SA; Yaghi S; Jayaraman M; Khatri P; Mistry EA
    Neurosurgery; 2020 Feb; 86(2):E156-E163. PubMed ID: 31758197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial.
    Sarraj A; Mlynash M; Savitz SI; Heit JJ; Lansberg MG; Marks MP; Albers GW
    JAMA Neurol; 2019 Jun; 76(6):682-689. PubMed ID: 30734042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.
    Lansberg MG; Mlynash M; Hamilton S; Yeatts SD; Christensen S; Kemp S; Lavori PW; Ortega-Gutierrez S; Broderick J; Heit J; Marks MP; Albers GW;
    JAMA Neurol; 2019 Apr; 76(4):447-453. PubMed ID: 30688974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients.
    Dittrich TD; Sporns PB; Kriemler LF; Rudin S; Nguyen A; Zietz A; Polymeris AA; Tränka C; Thilemann S; Wagner B; Altersberger VL; Piot I; Barinka F; Hänsel M; Gensicke H; Engelter ST; Lyrer PA; Sutter R; Nickel CH; Katan M; Peters N; Michels L; Kulcsár Z; Karwacki GM; Pileggi M; Cereda C; Wegener S; Bonati LH; Fischer U; Psychogios M; De Marchis GM
    Int J Stroke; 2023 Jul; 18(6):697-703. PubMed ID: 36367319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion Imaging Mismatch Profiles in the Early Thrombectomy Window: A Single-Center Analysis.
    Schwarz G; Agostoni EC; Saliou G; Hajdu SD; Salerno A; Dunet V; Michel P; Strambo D
    Stroke; 2023 May; 54(5):1182-1191. PubMed ID: 37026456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of Endovascular Thrombectomy by Mode of Onset: Secondary Analysis of the DAWN Trial.
    Jadhav AP; Aghaebrahim A; Jankowitz BT; Haussen DC; Budzik RF; Bonafe A; Bhuva P; Yavagal DR; Hanel RA; Hassan AE; Ribo M; Cognard C; Sila CA; Zhang Y; Smith WS; Saver JL; Liebeskind DS; Nogueira RG; Jovin TG
    Stroke; 2019 Nov; 50(11):3141-3146. PubMed ID: 31570085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome.
    de Havenon A; Mlynash M; Kim-Tenser MA; Lansberg MG; Leslie-Mazwi T; Christensen S; McTaggart RA; Alexander M; Albers G; Broderick J; Marks MP; Heit JJ;
    Stroke; 2019 Mar; 50(3):632-638. PubMed ID: 30726184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial.
    Liebeskind DS; Saber H; Xiang B; Jadhav AP; Jovin TG; Haussen DC; Budzik RF; Bonafe A; Bhuva P; Yavagal DR; Hanel RA; Ribo M; Cognard C; Sila C; Hassan AE; Smith WS; Saver JL; Nogueira RG;
    Stroke; 2022 Mar; 53(3):742-748. PubMed ID: 34727737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel selection paradigms for endovascular stroke treatment in the extended time window.
    Bouslama M; Haussen DC; Rodrigues G; Barreira C; Frankel M; Nogueira RG
    J Neurol Neurosurg Psychiatry; 2021 Nov; 92(11):1152-1157. PubMed ID: 34117100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular thrombectomy for DAWN- and DEFUSE-3 ineligible acute ischemic stroke patients: a systematic review and meta-analysis.
    Morsi S; Ghozy S; Elfil M; Tolba H; Rabenstein A; Kadirvel R; Kallmes DF
    J Neurol; 2024 May; 271(5):2230-2237. PubMed ID: 38308162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.